Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Houbiers

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Gastroenterology|July 13, 2000
Acute pancreatitis attributed to the use of interferon alfa-2bI A Eland, M C Rasch, M J Sturkenboom, et al.
The Journal of Rheumatology|October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activityBert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
British Journal of Cancer|August 10, 2007
Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III studyG Verset, C Verslype, H Reynaert, et al.
Annals of the Rheumatic Diseases|January 18, 2006
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritisD Baeten, J Houbiers, E Kruithof, et al.
European Journal of Immunology|June 1, 1993
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytesH W Nijman, J G Houbiers, M P Vierboom, et al.
Circulation|March 11, 1998
Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trialL M van de Watering, J Hermans, J G Houbiers, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II studyJean-Luc Van Laethem, Anne Demols, France Gay, et al.
British Journal of Cancer|September 1, 1995
Antibodies against p53 are associated with poor prognosis of colorectal cancerJ G Houbiers, S H van der Burg, L M van de Watering, et al.
Oncology|February 17, 2005
Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II studyJ-L Van Laethem, Ph Van Maele, C Verslype, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trialA Demols, I Borbath, M Van den Eynde, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Gastroenterology|July 13, 2000
Acute pancreatitis attributed to the use of interferon alfa-2bI A Eland, M C Rasch, M J Sturkenboom, et al.
The Journal of Rheumatology|October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activityBert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
British Journal of Cancer|August 10, 2007
Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III studyG Verset, C Verslype, H Reynaert, et al.
Annals of the Rheumatic Diseases|January 18, 2006
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritisD Baeten, J Houbiers, E Kruithof, et al.
European Journal of Immunology|June 1, 1993
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytesH W Nijman, J G Houbiers, M P Vierboom, et al.
Circulation|March 11, 1998
Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trialL M van de Watering, J Hermans, J G Houbiers, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II studyJean-Luc Van Laethem, Anne Demols, France Gay, et al.
British Journal of Cancer|September 1, 1995
Antibodies against p53 are associated with poor prognosis of colorectal cancerJ G Houbiers, S H van der Burg, L M van de Watering, et al.
Oncology|February 17, 2005
Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II studyJ-L Van Laethem, Ph Van Maele, C Verslype, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trialA Demols, I Borbath, M Van den Eynde, et al.
Pageof 6